This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Millennium Pharmaceuticals Limited. Active years: 2011.
Company Filing History:
Years Active: 2011
Title: Sian Griffiths: Innovator in CCR2 Antagonist Compounds
Introduction
Sian Griffiths is a notable inventor based in Westborough, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as antagonists of CCR2. With a total of 2 patents, his work is pivotal in addressing various inflammatory, allergic, and autoimmune diseases.
Latest Patents
Griffiths' latest patents focus on compounds that are useful as antagonists of CCR2. The first patent presents compounds of general formula (I) or a pharmaceutically acceptable salt thereof, where X, n, Y, and R are defined generally and in subsets. These compounds act as inhibitors of CCR2, making them valuable for treating a range of inflammatory, allergic, and autoimmune conditions. The second patent reiterates similar findings, emphasizing the importance of these compounds in medical applications.
Career Highlights
Sian Griffiths is associated with Millennium Pharmaceuticals Limited, where he continues to innovate and contribute to the pharmaceutical industry. His expertise in developing CCR2 antagonists has positioned him as a key player in the field.
Collaborations
Griffiths has collaborated with notable colleagues, including Amy M Elder and Shomir Ghosh. These partnerships enhance the research and development efforts within his team.
Conclusion
Sian Griffiths is a distinguished inventor whose work on CCR2 antagonists has the potential to transform treatment options for various diseases. His contributions to the pharmaceutical field are significant and continue to impact medical research positively.